Suicide IdeationNCT07039058
Brief DBT Skills Training for Coping With Suicidal Ideation
A study testing Brief Dialectical Behavior Therapy-Skills Training and Relaxation in people with Suicide Ideation and Coping Skills, run by Muhammed Ali Boztepe at 1 site in Turkey (Türkiye).
Trial summary
The goal of this clinical trial is to learn if Brief Dialectical Behavior Therapy Skills Training (DBT-BST) can prevent suicidality in adults. The main questions it aims to answer are: Does DBT-BST provide coping strategies (e.g., emotion regulation) to participants with suicidal ideation? Does DBT-BST lower… Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Suicide Ideation, Coping Skills, Emotion Regulation
- What is being tested?
- Brief Dialectical Behavior Therapy-Skills Training and Relaxation
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 0 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- Oct 2025to Jan 2026
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- being 18 years of age or older
- having suicidal ideation in the last 3 months
- not having received any psychological treatment in the last 1 month
- living in Aydın/Türkiye where the intervention will be implemented
- giving consent for participation
Who cannot join
- not speaking Turkish
- loss or trauma in the last 1 year
- pharmacological treatment
Trial locations and contacts
1 site in 1 country.
Turkey (Türkiye)1 site
Aydın Adnan Menderes University, Suicide and Stress Research Laboratory
Aydin, Aydın, 09500
About this study
Official title: Brief Dialectical Behavior Therapy-Skills Training for Coping With Suicidal Ideation: A Randomized Controlled Trial
The goal of this clinical trial is to learn if Brief Dialectical Behavior Therapy Skills Training (DBT-BST) can prevent suicidality in adults. The main questions it aims to answer are:
- Does DBT-BST provide coping strategies (e.g., emotion regulation) to participants with suicidal ideation?
- Does DBT-BST lower participants' suicide ideation?
Researchers will compare DBT-BST to relaxation to see if DBT-BST works to reduce suicidal ideation.
Participants will:
- Receive DBT-BST in a single 60-minute, in-person, individual session.
- Be asked to use these skills as self-help and for crisis prevention.
- Conditions
- Suicide Ideation, Coping Skills, Emotion Regulation
- Being tested
- Brief Dialectical Behavior Therapy-Skills Training, Relaxation
- Keywords
- Dialectical Behavior Therapy, Skills Training, Suicide ideation, Randomized
- Medical subject headings
- Emotional Regulation
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Brief Dialectical Behavior Therapy-Skills TrainingBehavioural
The intervention is administered in a single session, lasting approximately 60 minutes and conducted in person. It is important to note that there are no ongoing sessions.
In the intervention, participants are provided with 5 basic skills of Dialectical Behavior Therapy: 1) mindfulness, 2) mindfulness of current emotions, 3) opposite-to-emotion action, 4) distraction, and 5) changing body chemistry. These strategies are grouped under 3 categories: 1) Mindfulness, 2) Emotion regulation (mindfulness of current emotions, opposite-to-emotion action), 3) Tolerating distress (distraction, changing body chemistry). These skills are not designed to treat or solve the crisis. The main aim is to provide effective coping mechanisms that can be implemented quickly before the crisis escelates, to help overcome the intense emotional pain and keep the person alive.
RelaxationBehavioural
The control group will be subjected to a relaxation exercise, with the objective of managing participant expectations, researcher attention/interest, and time spent, as well as providing a coping strategy for stress.
| Study group | Role | What they receive |
|---|---|---|
| Brief Dialectical Behavior Therapy-Skills Training | Experimental | Not described Receives: Behavioral: Brief Dialectical Behavior Therapy-Skills Training |
| Relaxation control group | Active comparator | Not described Receives: Behavioral: Relaxation |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change from Baseline in the Suicidality at 1 Month as Assessed by Suicide Probability Scale
36 is equivalent to the lowest suicidality, and 144 indicates the highest suicidality.
Measured: From enrollment to the end of intervention at 1 week and follow-up at 1 month
Change from Baseline in the Suicidal Cognitions at 1 Month as Assessed by Suicide Cognitions Scale
18 is equivalent to the lowest suicidal cognitions, and 90 indicates the highest suicidal cognitions.
Measured: From enrollment to the end of intervention at 1 week and follow-up at 1 month
Change from Baseline in the Hopelessness at 1 Month as Assessed by Beck Hopelessness Scale
Zero is equivalent to the lowest hopelessness, and 20 indicates the highest hopelessness.
Measured: From enrollment to the end of intervention at 1 week and follow-up at 1 month
Change from Baseline in the Emotion Regulation Skills at 1 Month as Assessed by Emotion Regulation Skills Questionnaire
Zero is equivalent to the lowest emotion regulation skills, and 108 indicates the highest skills.
Measured: From enrollment to the end of intervention at 1 week and follow-up at 1 month
Change from Baseline in the Difficulties in Emotion Regulation at 1 Month as Assessed by Difficulties in Emotion Regulation Scale-16
16 is equivalent to the lowest difficulties, and 80 indicates the highest difficulties in emotion regulation.
Measured: From enrollment to the end of intervention at 1 week and follow-up at 1 month
Secondary outcomes (1)
Change from Baseline in the Depression, Anxiety, and Stress at 1 Month as Assessed by Depression Anxiety Stress Scale-21 (DASS-21)
Higher points are equivalent to higher symptoms as assessed by the related subscale of DASS-21. Each subscale ranges from 0 to 28.
Measured: From enrollment to the end of intervention at 1 week and follow-up at 1 month
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted26 Jun 2025
- Study startOct 2025 (estimated)
- Primary completionJan 2026 (estimated)
- Study completionJan 2026 (estimated)
Why it stopped: Study was not initiated due to lack of resources.
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Suicide IdeationStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 0 participants (actual)
Sponsor and investigators
- Lead sponsor
- Muhammed Ali Boztepe
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor-investigator, Muhammed Ali Boztepe, Aydin Adnan Menderes University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07039058
- Sponsor's protocol ID
- BriefDBT-ST30/05/2025
- Status last verified
- Sep 2025
- First submitted
- 18 Jun 2025
- Last updated
- 8 Sep 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 8 Sep 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Brief Dialectical Behavior Therapy-Skills Training for Coping With Suicidal Ideation: A Randomized Controlled Trial
- ClinicalTrials.gov ID
- NCT07039058
- Acronym / sponsor ID
- BriefDBT-ST30/05/2025
- Conditions
- Suicide Ideation, Coping Skills, Emotion Regulation
- Keywords
- Dialectical Behavior Therapy, Skills Training, Suicide ideation, Randomized
- Study type
- Interventional
- Recruitment status
- WithdrawnReason stopped: Study was not initiated due to lack of resources.
- Enrolment
- 0 participants (actual)
- Lead sponsor
- Muhammed Ali BoztepeUniversity, hospital or other
- Study start
- Oct 2025 (estimated)
- Primary completion
- Jan 2026 (estimated)
- Study completion
- Jan 2026 (estimated)
- First posted
- 26 Jun 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this clinical trial is to learn if Brief Dialectical Behavior Therapy Skills Training (DBT-BST) can prevent suicidality in adults. The main questions it aims to answer are:
- Does DBT-BST provide coping strategies (e.g., emotion regulation) to participants with suicidal ideation?
- Does DBT-BST lower participants' suicide ideation?
Researchers will compare DBT-BST to relaxation to see if DBT-BST works to reduce suicidal ideation.
Participants will:
- Receive DBT-BST in a single 60-minute, in-person, individual session.
- Be asked to use these skills as self-help and for crisis prevention.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Brief Dialectical Behavior Therapy-Skills Training | Experimental | Behavioral: Brief Dialectical Behavior Therapy-Skills Training |
| Relaxation control group | Active comparator | Behavioral: Relaxation |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (5 listed)
- being 18 years of age or older
- having suicidal ideation in the last 3 months
- not having received any psychological treatment in the last 1 month
- living in Aydın/Türkiye where the intervention will be implemented
- giving consent for participation
Key exclusion criteria (3 listed)
- not speaking Turkish
- loss or trauma in the last 1 year
- pharmacological treatment
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Brief Dialectical Behavior Therapy-Skills TrainingThe intervention is administered in a single session, lasting approximately 60 minutes and conducted in person. It is important to note that there are no ongoing sessions. In the intervention, participants are provided with 5 basic skills of Dialectical Behavior Therapy: 1) mindfulness, 2) mindfulness of current emotions, 3) opposite-to-emotion action, 4) distraction, and 5) changing body chemistry. These strategies are grouped under 3 categories: 1) Mindfulness, 2) Emotion regulation (mindfulness of current emotions, opposite-to-emotion action), 3) Tolerating distress (distraction, changing body chemistry). These skills are not designed to treat or solve the crisis. The main aim is to provide effective coping mechanisms that can be implemented quickly before the crisis escelates, to help overcome the intense emotional pain and keep the person alive. | Behavioural | Brief Dialectical Behavior Therapy-Skills Training |
| RelaxationThe control group will be subjected to a relaxation exercise, with the objective of managing participant expectations, researcher attention/interest, and time spent, as well as providing a coping strategy for stress. | Behavioural | Relaxation control group |
Primary outcome
Change from Baseline in the Suicidality at 1 Month as Assessed by Suicide Probability Scale
Time frame: From enrollment to the end of intervention at 1 week and follow-up at 1 month
36 is equivalent to the lowest suicidality, and 144 indicates the highest suicidality.
Change from Baseline in the Suicidal Cognitions at 1 Month as Assessed by Suicide Cognitions Scale
Time frame: From enrollment to the end of intervention at 1 week and follow-up at 1 month
18 is equivalent to the lowest suicidal cognitions, and 90 indicates the highest suicidal cognitions.
Change from Baseline in the Hopelessness at 1 Month as Assessed by Beck Hopelessness Scale
Time frame: From enrollment to the end of intervention at 1 week and follow-up at 1 month
Zero is equivalent to the lowest hopelessness, and 20 indicates the highest hopelessness.
Change from Baseline in the Emotion Regulation Skills at 1 Month as Assessed by Emotion Regulation Skills Questionnaire
Time frame: From enrollment to the end of intervention at 1 week and follow-up at 1 month
Zero is equivalent to the lowest emotion regulation skills, and 108 indicates the highest skills.
Change from Baseline in the Difficulties in Emotion Regulation at 1 Month as Assessed by Difficulties in Emotion Regulation Scale-16
Time frame: From enrollment to the end of intervention at 1 week and follow-up at 1 month
16 is equivalent to the lowest difficulties, and 80 indicates the highest difficulties in emotion regulation.
1 secondary outcome
Change from Baseline in the Depression, Anxiety, and Stress at 1 Month as Assessed by Depression Anxiety Stress Scale-21 (DASS-21)
Time frame: From enrollment to the end of intervention at 1 week and follow-up at 1 month
Results and safety
The study was withdrawn before enrolling participants, so there are no results.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 8 Sep 2025.
- Individual participant dataSharing planned: Undecided
Related trials for Suicide Ideation
Not yet recruiting
BEAR for Women Who Have Experienced Sexual Assault and Have Suicidal Thoughts
Sexual Assault and Rape, Suicidal Thoughts
Active, not recruiting
Motivational Interviewing to Address Suicidal Ideation for Veterans at High Risk for Suicide
Suicide, Attempted, Suicidal Ideation
Recruiting
Effects of Transcranial Direct Current Stimulation (tDCS) in the Management of Suicidal Ideation
Depression and Suicide
Recruiting
Developing a Recovery-Oriented Suicide Prevention Program for Young People at Clinical High Risk for Psychosis
Clinical High Risk for Psychosis (CHR), Suicidal Ideation
Not yet recruitingPhase 2
Intravenous Ketamine for Acute Suicidal Crisis and Psychiatric Hospital Length of Stay
Suicidal Ideation, Suicidal Behavior
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Brief Dialectical Behavior Therapy-Skills Training and Relaxation in people with Suicide Ideation and Coping Skills, run by Muhammed Ali Boztepe at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: withdrawn, as of the sponsor's last update on 8 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study was withdrawn before enrolling participants, so there are no results.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change from Baseline in the Suicidality at 1 Month as Assessed by Suicide Probability Scale (time frame: From enrollment to the end of intervention at 1 week and follow-up at 1 month). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Sep 2025.